1) Qin Chen*, Rong Deng, Xian Zhao, Haihua Yuan, Hailong
Zhang, Jinzhuo Dou, Ran Chen, Hui Jin, Yanli Wang, Jian Huang, Jianxiu Yu*. SUMOylation of EphB1 suppresses neuroblastoma tumorigenesis via
inhibiting PKCγ activation. Cellular Physiology and Biochemistry, 2017, in revision. 2) Yuzhang Du, Guofang Hou, Hailong Zhang, Jinzhuo
Dou, Jianfeng He, Yanming Guo, Lian Li, Ran Chen, Yanli
Wang, Rong Deng, Bin Jiang, Xian Zhao* and Jianxiu Yu*. SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its
function. Nucleic Acids Research, 2017, in Revision. 3) Haihua Yuan, Rong Deng, Xian Zhao, Ran Chen, Guofang Hou,
Hailong Zhang, Yanli Wang, Ming Xu, Bin Jiang*, Jianxiu Yu*. SUMO1 modification of KHSRP regulates tumorigenesis by
preventing the TL-G-Rich miRNA biogenesis. Mol Cancer, 2017, Accepted. 4) Jing Wang, Rong Deng, Nan Cui, Hailong Zhang, Tianqi Liu,
Jinzhuo Dou, Xian Zhao, Ran Chen, Yanli Wang, Jianxiu Yu*, Jian Huang*. Src SUMOylation inhibits tumor growth via decreasing
FAK Y925 phosphorylation. Neoplasia, 2017, Accepted on Sep 1, 2017. 5) Jiang H, Deng R, Yang X, Shang J, Lu S, Zhao Y, Song K, Liu
X, Zhang Q, Chen Y, Chinn YE, Wu G, Li J, Chen G, Yu J*, Zhang J*. Peptidomimetic inhibitors of APC-Asef interaction block colorectal
cancer migration. Nat Chem Biol. 2017, 13(9): 994-1001. Cancer Discovery Research Watch: http://cancerdiscovery.aacrjournals.org/content/early/2017/08/03/2159-8290.CD-RW2017-145. 6) Zhao X, Deng R, Wang Y, Zhang H, Dou J, Li L, Du Y, Chen R,
Cheng J, Yu J*. Twist1/Dnmt3a and miR186 establish a regulatory circuit that
controls inflammation-associated prostate cancer progression. Oncogenesis. 2017, 6(4): e315. 7) Zhu C, Chen C, Chen R, Deng R, Zhao X, Zhang H, Duo J, Chen
Q, Jin H, Wang Y, Huang J, Xu M, Yu J*. K259-SUMOylation of DGCR8 promoted by p14ARF exerts a
tumor-suppressive function. J Mol Cell Biol. 2016 Jul 19. pii: mjw030. 8) Zhao X, Wang Y, Deng R, Zhang H, Dou J, Yuan H, Hou G, Du
Y, Chen Q, Yu J*. miR186 suppresses prostate cancer progression by targeting Twist1. Oncotarget. 2016, 7(22): 33136-51. 9) Chen C, Zhu C, Huang J, Zhao X, Deng R, Zhang H, Dou J,
Chen Q, Xu M, Yuan H, Wang Y, Yu J*. SUMOylation of TARBP2 regulates miRNA/siRNA efficiency. Nature Commun. 2015, 6:8899. 10) Lu S, Deng R, Jiang H, Song H, Li S, Shen Q, Huang W,
Nussinov R, Yu J*, Zhang J*. The Mechanism of ATP-Dependent Allosteric Protection of Akt Kinase
Phosphorylation. Structure. 2015, 23(9):1725-34. 11) Zhu C, Chen C, Huang J, Zhang H, Zhao X, Deng R, Dou J,
Jin H, Chen R, Xu M, Chen Q, Wang Y, Yu J*. SUMOylation at K707 of DGCR8 controls direct function of primary
microRNA. Nucleic Acids Res. 2015, 43(16):7945-60. 12) Chen Q, Zhao X, Zhang H, Yuan H, Zhu M, Sun Q, Lai X, Wang
Y, Huang J, Yan J, Yu J*. MiR-130b suppresses prostate cancer metastasis through
down-regulation of MMP2. Mol Carcinogen. 2015, 54(11):1292-300. 13) Lai X, Chen Q, Zhu C, Deng R, Zhao X, Chen C, Wang
Y. Yu J*, Huang J*. Regulation of RPTPα-c-Src signalling pathway by miR-218. FEBS J, 2015, 282(14):2722-34. 14) Deng R, Zhao X, Qu Y, Chen C, Zhu C, Zhang H, Yuan H, Jin
H, Liu X, Wang Y, Chen Q, Huang J, Yu J*. Shp2 SUMOylation promotes ERK activation and hepatocellular
carcinoma development. Oncotarget, 2015, 6(11):9355-69. 15) Xu M, Zhu C, Zhao X, Chen C, Zhang H, Yuan H, Deng R, Dou
J, Wang Y, Huang J, Chen Q, Jiang B, Yu J*. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the
core epithelial-to-mesenchymal transition-inducing tranion factors. Oncotarget. 2015, 6(2): 979-94. 16) Sun Q, Zhao X, Liu X, Wang Y, Huang J, Jiang B, Chen Q, Yu J*. miR-146a functions as a tumor suppressor in prostate cancer by
targeting Rac1. Prostate. 2014, 74(16):1613-21. 17) Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng R, Wang Y, Huang
J, Xu M, Yan J, Yu J*. lncRNA H19/miR-675 axis represses prostate cancer metastasis by
targeting TGFBI. FEBS J. 2014, 281:3766-3775. 18) Qu Y,
Chen Q, Lai X, Zhu C, Chen C, Zhao X,
Deng R, Xu M, Yuan H, Wang Y, Yu J*, Huang J*. SUMOylation of Grb2 enhances the ERK activity by increasing its
binding with Sos1. Mol Cancer, 2014, 13(1):95. 19) Liu X, Chen Q, Yan J, Wang Y, Zhu C, Chen C, Zhao X, Xu M,
Sun Q, Deng R, Zhang H, Qu Y, Huang J, Jiang B, Yu J*. MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by
possible enhancing survival of natural killer cell-resistant
circulating tumour cells. Cell Death Dis. 2013, 4:e928. 20) Yu J*, Deng R, Zhu HH, Zhang SS, Zhu C, Montminy M, Davis R, Feng GS*. Modulation of fatty acid synthase degradation by concerted action
of p38 MAP kinase, E3 ligase COP1 and SH2-tyrosine phosphatase
Shp2. J Biol Chem. 2013, 288(6):3823-30. 21) Huang J, Yan J, Zhang J, Zhu S, Wang Y, Shi T, Zhu C, Chen
C, Liu X, Cheng J, Mustelin T, Feng GS, Chen G, Yu J*. SUMO1 modification of PTEN regulates tumorigenesis by controlling
its association with the plasma membrane. Nat Commun. 2012, 3:911. http://f1000.com/717847819 . 22) Liu X, Wang Y, Sun Q, Yan J, Huang J, Zhu S, Yu J*. Identification of microRNA tranome involved in human natural killer
cell activation. Immunol Lett. 2012, 143(2):208-17. 23) Yu J, Zhang D, Liu J, Li J, Yu Y, Wu XR, Huang C*. RhoGDI SUMOylation at Lys-138 Increases Its Binding Activity to Rho
GTPase and its Inhibiting Cancer Cell Motility. J Biol Chem. 2012, 287(17):13752-60. 24) Yu J*, Zhang SS, Saito K, Williams S, Arimura Y, Ma Y, Ke Y, Baron V,
Mercola D, Feng GS, Adamson E*, Mustelin T. PTEN regulation by Akt-EGR1-ARF-PTEN axis. EMBO J. 2009, 28(1):21-33. 25) Yu J, Baron V, Mercola D, Mustelin T, Adamson ED*. A network of p73, p53 and Egr1 is required for efficient apoptosis
in tumor cells. Cell Death and Differentiation. 2007, 14(3):436-46. 26) Yu J, de Belle I, Liang H, Adamson ED*. Coactivating factors p300 and CBP are tranionally crossregulated by
Egr1 in prostate cells, leading to divergent responses. Mol Cell, 2004, 15(1): 83-94. http://www.f1000biology.com/article/id/1019957/evaluation |
